Medopharm — Potassium Exporter Profile
Indian Pharmaceutical Exporter · #13 for Potassium · $3.4M export value · DGFT Verified
Medopharm is the #13 Indian exporter of Potassium with $3.4M in export value and 68 verified shipments. Medopharm holds a 0.5% market share in Potassium exports across 14 countries. The company exports 21 pharmaceutical products worth $50.2M across 10 therapeutic categories.
Medopharm — Potassium Export Profile: Buyers & Destinations
Where Does Medopharm Export Potassium?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED ARAB EMIRATES | $431.6K | 39 | 18.7% |
| ISRAEL | $374.0K | 10 | 16.2% |
| NETHERLANDS | $323.4K | 17 | 14.0% |
| NICARAGUA | $174.7K | 9 | 7.6% |
| ETHIOPIA | $156.9K | 17 | 6.8% |
| YEMEN DEMOCRATIC | $86.2K | 4 | 3.7% |
| OMAN | $86.2K | 4 | 3.7% |
| SYRIA | $73.7K | 4 | 3.2% |
| PERU | $66.2K | 5 | 2.9% |
| BOTSWANA | $65.1K | 8 | 2.8% |
Medopharm exports Potassium to 29 countries. The largest destination is UNITED ARAB EMIRATES accounting for 18.7% of Medopharm's Potassium shipments, followed by ISRAEL (16.2%) and NETHERLANDS (14.0%). These destinations reflect Medopharm's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Potassium from Medopharm?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S. UNRWA - HEAD FIELD LOGISTICS O | ISRAEL | $252.5K | 6 |
| MAF PHARMA FOR PHARMACEUTICAL | YEMEN DEMOCRATIC | $172.4K | 8 |
| SEVEN PHARMA NICARAGUA S.A | NICARAGUA | $120.4K | 5 |
| IDA TRADING MEAC/OKUEHNE+NAGEL LLC. | UNITED ARAB EMIRATES | $90.8K | 8 |
| IDA TRADING MEA C/OKUEHNE+NAGEL LLC | UNITED ARAB EMIRATES | $89.8K | 9 |
| M/S. DB SCHENKER LOGISTICS NETHERLA | NETHERLANDS | $81.3K | 3 |
| IDA TRADING MEAC OKUEHNE NAGEL LLC | UNITED ARAB EMIRATES | $72.5K | 6 |
| M S UNRWA HEAD FIELD LOGISTICS O | ISRAEL | $70.5K | 2 |
| M/S. IMRES | NETHERLANDS | $64.4K | 3 |
| IMRES | NETHERLANDS | $56.8K | 3 |
Medopharm supplies Potassium to 68 buyers globally. The largest buyer is M/S. UNRWA - HEAD FIELD LOGISTICS O (ISRAEL), followed by MAF PHARMA FOR PHARMACEUTICAL (YEMEN DEMOCRATIC) and SEVEN PHARMA NICARAGUA S.A (NICARAGUA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Potassium Export Value and How Much Does Medopharm Contribute?
India exported $225.9M worth of Potassium through 15,000 shipments from 877 suppliers to 177 countries, serving 2,474 buyers globally. Medopharm contributes $3.4M to this total, accounting for 0.5% of India's Potassium exports. Medopharm ships Potassium to 29 countries through 68 buyers.
What Is the Average Shipment Value for Medopharm's Potassium Exports?
Medopharm's average Potassium shipment value is $50.0K per consignment, based on 68 shipments totaling $3.4M. The largest destination is UNITED ARAB EMIRATES (18.7% of Medopharm's Potassium exports).
How Does Medopharm Compare to Other Indian Potassium Exporters?
Medopharm ranks #13 among 877 Indian Potassium exporters with a 0.5% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($67.3M), AUROBINDO PHARMA LIMITED ($29.9M), MICRO LABS LIMITED ($25.1M). Medopharm processed 68 shipments to 14 destination countries.
What Potassium Formulations Does Medopharm Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMOXICILLIN AND CLAVULANATE POTASSIUM FO | $632.2K | 34 |
| CLAVOMAF 312 5 AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION USP 312 5MG 5ML 39440 X 100 ML NOS | $84.0K | 2 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION USP 312.5MG/5ML (100833 X 60ML) - NOS | $83.6K | 3 |
| AMOXICILLIN AND POTASSIUM CLAVULANATE FO | $82.8K | 3 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION USP 312.5MG/5ML | $65.8K | 7 |
| CLEDOMOX 312 5 AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION USP 312 5MG 5ML 58800 X 100ML NOS | $50.0K | 1 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION USP 312.5MG/5ML (59706X 100ML) - NOS | $50.0K | 1 |
| CURAM 625 (AMOXICILLIN AND POTASSIUM CLAVULANATE TABLETS BP 625MG) (32763 X 3 X5) - BOX | $50.0K | 1 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION USP 312 5MG 5ML 43127X100ML NOS | $47.4K | 1 |
| CLAVOMAF 156 25 AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION USP 156 25MG 5ML 29980 X 100ML NOS | $42.9K | 2 |
Medopharm exports 91 distinct Potassium formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMOXICILLIN AND CLAVULANATE POTASSIUM FO with 34 shipments worth $632.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Medopharm Compare to Nearest Potassium Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MYLAN LABORATORIES LIMITED | $4.5M | 91 | 3 | $50.0K |
| 12 | APL HEALTHCARE LIMITED | $4.0M | 81 | 1 | $50.0K |
| 13 | MEDOPHARM ★ | $3.4M | 68 | 14 | $50.0K |
| 10 | ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED | $400.0K | 8 | 1 | $50.0K |
Medopharm ranks #13 among 877 Indian Potassium exporters. Average shipment value of $50.0K compared to the market average of $257.6K. The closest competitors by value are MYLAN LABORATORIES LIMITED and APL HEALTHCARE LIMITED.
Which Indian Ports Ship Potassium Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,108 | 7.4% |
| SAHAR AIR | 916 | 6.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 911 | 6.1% |
| DELHI AIR CARGO ACC (INDEL4) | 791 | 5.3% |
| HYDERABAD ICD (INSNF6) | 767 | 5.1% |
| DELHI AIR | 715 | 4.8% |
| JNPT/ NHAVA SHEVA SEA | 645 | 4.3% |
| HYDERABAD ICD | 644 | 4.3% |
Geopolitical & Trade Policy Impact on Medopharm's Potassium Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medopharm. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions have particularly impacted trade corridors through the Persian Gulf and the Strait of Hormuz, vital for India's drug shipments. (pharmaceuticalcommerce.com)
Conversely, US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of 100% tariffs on branded or patented pharmaceutical products by the US in October 2025 poses a significant challenge. While generic drugs may remain largely unaffected, companies like Medopharm must navigate these policy shifts carefully. (itisbl.com)
The recent India–European Union Free Trade Agreement, concluded in January 2026, offers a favorable development. The agreement eliminates tariffs on most European pharmaceutical exports to India and vice versa, potentially enhancing market access for Indian companies in the EU. (en.wikipedia.org)
Medopharm — Regulatory Compliance & Quality Standards
India's pharmaceutical industry has made significant strides in regulatory compliance, with the country surpassing the US in the number of FDA-registered generic manufacturing sites as of 2024. This achievement reflects improved adherence to international quality standards, a critical factor for exporters like Medopharm. (business-standard.com)
However, the industry faces challenges related to quality compliance, as evidenced by incidents involving contaminated products. Maintaining rigorous quality control measures is essential for sustaining global trust and market access. (economictimes.indiatimes.com)
About Medopharm
Medopharm exports 21 products worth $50.2M. Beyond Potassium, top products include Amoxicillin, Metronidazole, Paracetamol, Albendazole, Ciprofloxacin. View the complete Medopharm profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Potassium — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Potassium shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medopharm matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 152 individual customs records matching Medopharm exporting Potassium, covering 91 formulations to 29 countries via 68 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 177+ countries, 2,474+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Potassium Export Data from Medopharm
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medopharm's Potassium exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medopharm
Full Company Profile →
21 products · $50.2M total trade · 10 categories
Potassium Stats
Company Overview
Top Products by Medopharm
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medopharm.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Potassium. For current shipment-level data, contact TransData Nexus.